Thursday, May 26, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Hyderabad | Hyderabad Drives Innovation For Covid Therapies

Hyderabad drives innovation for Covid therapies

By M. Sai Gopal
Published: Published Date - 11:46 PM, Sun - 9 May 21
Representational Image The latest therapy with links to the city is the glucose molecule 2-DG and its anti-Covid-19 therapeutic application that was given a green signal by Indian drug regulatory authorities

Hyderabad: Hyderabad continues to remain a preferred innovation hub for researchers and scientists involved in developing vaccines and anti-viral therapies for Covid-19. The latest therapy that has links to Hyderabad is the glucose molecule 2-deozy-D-glucose (2-DG) and its anti-Covid-19 therapeutic application that was given a green signal by the Indian drug regulatory authorities.

The anti-Covid-19 therapeutic application was developed by Delhi-based Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the Defence Research and Development Organisation (DRDO), in collaboration with city-based pharma giant Dr Reddy’s Laboratories and the Centre for Cellular and Molecular Biology (CCMB).

The INMAS has worked with Dr Reddy’s to develop the anti-Covid therapeutic application while at CCMB, the successful testing of the 2-deozy-D-glucose (2-DG) in coronavirus cell culture was take-up. “From testing of DRDO and Dr Reddy Lab’s 2-DG (2-deoxy-D-glucose) on coronavirus in cell culture at CCMB to successfully clearing the phase 3 trials, it will now be used on moderate to severe Covid-19 patients. DCGI approval has come,” the CCMB had tweeted on May 7.

Former Director and present advisor of CCMB Dr Rakesh Mishra said the anti-Covid-19 therapeutic application of 2-DG was the first drug tested in CCMB against the virus. The top geneticist congratulated the DRDO, Dr Reddy’s and the CCMB for bringing out such an innovative product.

According to INMAS, the clinical trial results of the molecule showed that it helps ‘in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in Covid patients’.

The Phase-III clinical trial was conducted on 220 patients between December 2020 to March 2021 at 27 Covid hospitals in Delhi, Uttar Pradesh, West Bengal, Gujarat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu.

Researchers familiar with the development said that Dr Reddy’s is expected to mass produce the molecule, which will be in the form of a powder. The drug will be prescribed as an adjunct or only as add-on to the already existing therapies.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • CCMB
  • Centre for Cellular and Molecular Biology
  • Defence Research and Development Organisation
  • Dr Reddy’s Laboratories

Related News

  • DRDO carries out successful maiden testfiring of Naval Anti-ship missile

  • Hyderabad-based CCMB develops India’s first mRNA vaccine tech

  • Study sheds light on how genes contribute to Type 2 diabetes

  • Milo CCMB: Students from TSWREIS to spend a week with top genetic researchers

  • Hyderabad’s CCMB scientists reveal 160-year-old human skeletons from Ajnala belong to martyrs of sepoy mutiny

  • NALSAR, AIC-CCMB sign MoU on collaboration

Latest News

  • Over 2.1 lakh candidates register for Group-I

    7 mins ago
  • French Open: Qinwen Zheng stuns Simona Halep in second round

    8 mins ago
  • Be thorough with profit and loss problems

    30 mins ago
  • India and its ties with other countries

    42 mins ago
  • Hyundai to invest Rs 1,400 crore in Telangana

    41 mins ago
  • Improve your reading speed with these techniques

    48 mins ago
  • GMM Pfaudler to expand in Hyderabad

    53 mins ago
  • Nalgonda: Palle Prahathi changes the face of villages

    55 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam